Thomas T. Thomas, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 822 shares at $18.00 ($15K) on 2021-09-07, disclosed to the SEC on 2021-09-09.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OPNT | SELL | 2021-08-20 | $16K | — | Filing → |
| OPNT | BUY | 2020-09-08 | $25K | — | Filing → |
| OPNT | SELL | 2018-05-18 | $45K | — | Filing → |